Alzheimer's Disease Trial, Recruiting NCT07075770 Sponsor: I.R.C.C.S. Fondazione Santa Lucia Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT07075770
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Alzheimer's disease based on specific medical guidelines (called IWG criteria)
  • Your score on a standard memory and thinking test (called the MMSE) falls between 20 and 28, indicating mild to moderate difficulty
  • Your brain scan or spinal fluid test has shown signs of a protein buildup linked to Alzheimer's disease (called amyloid)
  • Your overall level of dementia, measured by a standard rating scale (CDR), is mild or less
  • Your medical records show that your memory or thinking has been getting worse for more than six months
  • You have a caregiver who lives with you or sees you regularly and is available to take part
  • You live at home or in a care home that does not provide around-the-clock nursing care
  • Your general health is good enough to take part in a six-month study
  • Any medicines you take regularly have been the same for at least one month before the study begins
  • You are not taking any medications that are not allowed in this trial
  • You (and your caregiver) are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

  • You are unable to attend or complete the required check-up appointments at the start of the study
  • You were hospitalised or had a change in your regular medicines in the month before or during the initial screening period
  • You have been diagnosed with another type of dementia, such as Lewy body dementia, frontotemporal dementia, Huntington's disease, or a similar condition
  • You have another brain or nervous system condition, such as Parkinson's disease or motor neurone disease (ALS)
  • You have a condition causing sudden drops in blood pressure when standing (orthostatic hypotension) or problems with the body's automatic functions (confirm with trial site)
  • You have had a significant stroke or have extensive damage to the white matter of the brain
  • You have another serious brain condition, such as a tumour, severe head injury, or bleeding around the brain
  • You have a history of epilepsy or seizures
  • You have an infection, hormone problem, or other body-wide illness that affects the brain (for example, untreated low thyroid function or vitamin B12 deficiency)
  • You currently have a diagnosis of severe depression, schizophrenia, or bipolar disorder
  • You have a serious or unstable illness that could affect your ability to take part or be assessed safely
  • You have a disability that would prevent you from completing all parts of the study, such as severe vision or hearing loss
  • You regularly take strong painkiller medicines containing opioids
  • You drink more than approximately one litre of beer or 500ml of wine per day, or have signs of alcohol or drug misuse
  • In the opinion of the study doctor, there is any other reason you would not be suitable for the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giacomo Koch, Prof., IRCCS Santa Lucia Foundation

Phone: +390651501181

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
I.R.C.C.S. Fondazione Santa Lucia
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

integrated Alzheimer Disease Rating Scale (iADRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov